NEW YORK (GenomeWeb News) - Accelrys yesterday said fiscal second-quarter 2008 revenues fell around 2 percent as R&D spending dropped around 13 percent and profit shot up 75 percent.
Total receipts for the three months ended Sept. 30, 2007, dipped to $19.7 million from $20.2 million year over year.
Second-quarter revenue was impacted by “reduced revenues from de-emphasized products” and was offset in part by “continued growth in the solutions and services surrounding the company’s scientific operating platform product line,” the company said.
Accelrys’ R&D spending decreased to $4.3 million from $4.9 million year over year.
The firm’s net income rose to $1.6 million from $935,000 in the year-ago period.
Accelrys said it had around $64.9 million in cash, cash equivalents, and marketable securities as of Sept. 30.